Technology and environment, J. H. Ausubel and H. E. Sladovich, National Academy Press, Washington, D.C. (1989), 230 pages [isbn no.: 0-309-04075-2] U.S. list price: $35.00

1991 ◽  
Vol 10 (1) ◽  
pp. F6-F6
Author(s):  
John B. Rajan
Keyword(s):  
1998 ◽  
Vol 15 (1) ◽  
pp. 59-76 ◽  
Author(s):  
John Knight ◽  
C Sirmans ◽  
Geoffrey Turnbull
Keyword(s):  

PEDIATRICS ◽  
1991 ◽  
Vol 88 (3) ◽  
pp. 559-559
Author(s):  
FRANCES PAGE GLASCOE ◽  
WILLIAM O. MOORE ◽  
ANNA BAUMGAERTEL

P. Mayle. What's Happening to Me? New York: Carol Publishing, 1975; list price $8.95 (No. 6 on the 1990 bestseller list of books on child care from Ingram Book Co., distributor of trade books). In need of prompt revision to address AIDS-era issues, this book, which is written for adolescents in puberty, is an odd, amusing, and aggravating mixture of goofy cartoons designed to appeal to young children, a reading level which varies from elementary to high school, and medical content which ranges from accurate to euphemistic and incorrect (especially about acne treatment, fertilization of eggs, sex hormones, and female external genitalia). The emphasis on normal variability in penis and breast size is helpful as is the guilt-free acceptance of masturbation and encouragement to achieve social and mental maturity before having children. Despite the drawbacks, the book may be useful for prepubescent children who need light exposure to the issues of puberty. Parental guidance is advised, at least until a revision is published.


PEDIATRICS ◽  
1989 ◽  
Vol 84 (1) ◽  
pp. A50-A50
Author(s):  
Frances P. Glascoe ◽  
William R. Moore ◽  
James Henderson ◽  
Elaine D. Martin

Leach P. Your Baby and Child: From Birth to Age Five. New York, NY: Alfred A. Knopf; 1978; list price $24.45 (#4 on the 1988 bestseller list of books on child care of the Ingram Book Co, distributors of trade books). Addressing the effects of nature and nurture on development, Leach covers prenatal development through preschool with particular attention to infancy. Parents' roles, identical for mothers and fathers, are diverse and include controller of environments, model of ideal behavior, nurturer, and instructor. Management methods involve positive reinforcement, ignoring, and active listening; designed to be preventive, corrective, and instructive. Detailed information is given about specific practices including nutrition, stimulatory activities, illness, and education. There is some consideration of environmental forces, parenting difficulties, and the needs of exceptional children. While an intact family is not presumed, material resources are, and presence of a homemaker is advised until children reach three years of age. The text is moderately difficult to read, lacks organization and cross-referencing in the indices. However, the book is supported by numerous photographs and illustrations. The medical content was rated as fair but parents are prompted to seek medical attention appropriately.


2021 ◽  
pp. 193229682110675
Author(s):  
Mark C. Matli ◽  
Andrea B. Wilson ◽  
Leah M. Rappsilber ◽  
Farron P. Sheffield ◽  
Miranda L. Farlow ◽  
...  

On March 23, 2020, all insulin products were reclassified as biologics instead of drugs under the Biological Price Competition and Innovation (BPCI) Act of 2009. This allows biosimilar insulin products to be manufactured when the patent expires for the reference biologic, sometimes called the originator or brand name product. A biosimilar product may not be substituted for the reference biologic at the pharmacy counter unless the biosimilar undergoes further switch trials to earn the designation as an interchangeable biosimilar. Insulin glargine-yfgn 100 units/mL is the first biosimilar insulin to attain interchangeable status with the reference insulin glargine. In the INSTRIDE 1 and INSTRIDE 2 trials, insulin glargine-yfgn has proven noninferiority regarding blood glucose reduction and adverse effect profile versus reference insulin glargine; even in the INSTRIDE 3 trial in which treatment of diabetes was switched between insulin glargine-yfgn and reference insulin glargine throughout the trial without statistically significant changes to glucose levels or adverse effects. Insulin glargine-yfgn may be substituted at the pharmacy counter without consultation with the prescriber, in accordance with state laws. In suit with other biosimilars, insulin glargine-yfgn’s list price is significantly lower than other insulin glargine products. This increases market competition leading to decreases in costs of other insulin glargine products. Many patients who could not previously afford insulin therapy may now have significantly improved access to treatment. Providers will need education to increase awareness of these new biosimilars and interchangeable biosimilar insulin products, cost benefits, and substitution allowances.


1996 ◽  
Vol 33 (1) ◽  
pp. 147-157 ◽  
Author(s):  
Henrik A. Thomsen ◽  
Kenneth Kisbye

State-of-the-art on-line meters for determination of ammonium, nitrate and phosphate are presented. The on-line meters employ different measuring principles and are available in many different designs differing with respect to size, calibration and cleaning principle, user-friendliness, response time, reagent and sample consumption. A study of Danish experiences on several plants has been conducted. The list price of an on-line meter is between USD 8000 and USD 35,000. To this should be added the cost of sample preparation, design, installation and running-in. The yearly operating for one meter are in the range of USD 200-2500 and the manpower consumption is in the range of 1-5 hours/month. The accuracy obtained is only slightly smaller than the accuracy on collaborative laboratory analyses, which is sufficient for most control purposes.


Sign in / Sign up

Export Citation Format

Share Document